These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33238468)

  • 1. Addressing Latent Tuberculosis: New Advances in Mimicking the Disease, Discovering Key Targets, and Designing Hit Compounds.
    Campaniço A; Harjivan SG; Warner DF; Moreira R; Lopes F
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
    Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
    Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A whole genome bioinformatic approach to determine potential latent phase specific targets in Mycobacterium tuberculosis.
    Defelipe LA; Do Porto DF; Pereira Ramos PI; Nicolás MF; Sosa E; Radusky L; Lanzarotti E; Turjanski AG; Marti MA
    Tuberculosis (Edinb); 2016 Mar; 97():181-92. PubMed ID: 26791267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic plasticity between human and mycobacterial DNA: A review.
    Danjuma L; Ling MP; Hamat RA; Higuchi A; Alarfaj AA; Marlina ; Benelli G; Arulselvan P; Rajan M; Kumar Subbiah S
    Tuberculosis (Edinb); 2017 Dec; 107():38-47. PubMed ID: 29050770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality?
    Gupta VK; Kumar MM; Singh D; Bisht D; Sharma S
    Infect Dis (Lond); 2018 Feb; 50(2):81-94. PubMed ID: 28933243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can mycobacterial genomics generate novel targets as speed-breakers against the race for drug resistance.
    Chauhan RS; Chanumolu SK; Rout C; Shrivastava R
    Curr Pharm Des; 2014; 20(27):4319-45. PubMed ID: 24245760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis progresses through two phases of latent infection in humans.
    Colangeli R; Gupta A; Vinhas SA; Chippada Venkata UD; Kim S; Grady C; Jones-López EC; Soteropoulos P; Palaci M; Marques-Rodrigues P; Salgame P; Ellner JJ; Dietze R; Alland D
    Nat Commun; 2020 Sep; 11(1):4870. PubMed ID: 32978384
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Nunes JES; Duque MA; de Freitas TF; Galina L; Timmers LFSM; Bizarro CV; Machado P; Basso LA; Ducati RG
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tuberculosis: steady dynamics between past and present to imagine the future].
    Cabello C F
    Rev Med Chil; 2011 Jul; 139(7):829-32. PubMed ID: 22051818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent tuberculosis: is there a role for thioridazine?
    Sohaskey C
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):139-46. PubMed ID: 21548878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent tuberculosis infection: what we know about its genetic control?
    Kondratieva T; Azhikina T; Nikonenko B; Kaprelyants A; Apt A
    Tuberculosis (Edinb); 2014 Sep; 94(5):462-8. PubMed ID: 25104213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 4-Amino-Thieno[2,3-
    Harrison GA; Mayer Bridwell AE; Singh M; Jayaraman K; Weiss LA; Kinsella RL; Aneke JS; Flentie K; Schene ME; Gaggioli M; Solomon SD; Wildman SA; Meyers MJ; Stallings CL
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31511370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of nitrite acting as a stable and robust inducer of non-cultivability in Mycobacterium tuberculosis with physiological relevance.
    Gample SP; Agrawal S; Sarkar D
    Sci Rep; 2019 Jun; 9(1):9261. PubMed ID: 31239517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discovery in tuberculosis. New drug targets and antimycobacterial agents.
    Campaniço A; Moreira R; Lopes F
    Eur J Med Chem; 2018 Apr; 150():525-545. PubMed ID: 29549838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of Eis and expression of Wag31 and GroES in Mycobacterium tuberculosis cytosol under anaerobic culture conditions.
    Maurya VK; Singh K; Sinha S
    Indian J Exp Biol; 2014 Aug; 52(8):773-80. PubMed ID: 25141539
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.